Vanda Pharmaceuticals, a publicly traded maker of drugs to treat Non-24-Hour Sleep Wake Disorder and schizophrenia, has hired a health care in-house veteran as its new general counsel.

In addition to serving as GC, Timothy Williams also will be Vanda’s senior vice president and secretary, the Washington, D.C.-based biopharmaceutical company announced Monday. He most recently was executive VP, GC, chief compliance officer and corporate secretary at AgNovos Healthcare, a medical device company focused on bone health.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]